Current disease status-First occurrence of the cancer Page 3 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Searching for patients with untreated advanced melanoma to trial a new personalized cancer vaccine

Posted by on Feb 23, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to see if combining two medications, pembrolizumab (Keytruda) and RO7198457 (a new experimental vaccine) is better than just using pembrolizumab in treating advanced melanoma that has not been treated before. The main outcome that will be measured is how long the patients go without cancer growing. The study is being...

Read More

Looking for men with newly diagnosed prostate cancer to test an immune based therapy, Sipuleucel-T

Posted by on Feb 9, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluates the effectiveness of an immunotherapy in the treatment of newly diagnosed prostate cancer. The main outcome to be measured in this trial is the number of patients whose cancer does not progress within 3 years after immunotherapy injection. This trial is taking place in many sites across the USA.  The details...

Read More

Long-term outcomes of active surveillance for localized prostate cancer.

Posted by on Jan 31, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes of active surveillance (AS) in the treatment of localized prostate cancer. This study recommends the use of AS for men with localized prostate cancer. Some background Treatments for prostate cancer often result in serious side effects such as impaired bowel, bladder or sexual functions....

Read More

Searching for patients with untreated melanoma that has spread to trial a new treatment

Posted by on Jan 19, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to test the safety and effectiveness of adding a new drug called NKTR-214 to treatment with nivolumab (Opdivo) is better than just using nivolumab alone. The main outcomes that will be measured are how many people respond to treatment, how long the patients go without cancer growing or spreading, and overall...

Read More

Is the biosimilar drug ABP 125 as effective as bevacizumab in patients with lung cancer?

Posted by on Jan 17, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how safe and effective is biosimilar ABP 215 in non-small cell lung cancer (NSCLC), compared to bevacizumab (Avastin). This study concluded that this drug is as safe and effective as bevacizumab in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung...

Read More

Comparing robotic and laparoscopic surgery to treat right colon cancer

Posted by on Dec 30, 2018 in Colorectal cancer | 0 comments

In a nutshell This study compared robotic and laparoscopic complete mesocolic surgery (CMS) in patients with colon cancer. Researchers suggested that both surgeries were safe and associated with excellent outcomes. Some background Colorectal cancer is the third most common cancer in the US. After the standard treatment, 30 to 40% of the patients...

Read More

Comparing robot-assisted laparoscopic prostate surgery versus open prostate surgery

Posted by on Dec 11, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to compare traditional open surgery and robotic surgery to treat prostate cancer in terms of side effects. It found that there was no difference in side-effects like sexual function or urinary problems between the two surgeries. Some background Prostate surgery is a treatment option for prostate cancer. This surgery...

Read More